Modifications

Peter Mayne (voir la source)

Version du 6 septembre 2019 à 19:00

4 octets ajoutés , 6 septembre 2019 à 19:00

Ligne 28 : Ligne 28 :

Traduit avec www.DeepL.com/Translator

−

<ref>https://beyondthebandaid.com.au/dr-peter-mayne-mbbs-sydney-dpd-cardiff-idd-graz-facrrm/ Dr Peter Mayne MBBS (Sydney) DPD (Cardiff) IDD (Graz) FACRRM Dr Peter Mayne is a Honorary teaching associate Cardiff University Department of Medicine (Dermatology) and he is also an active member of [[ILADS]] (International Lyme and Associated Diseases Society) and has undergone physician training in Lyme disease in the USA. Dr Mayne is a rural general practitioner who has been treating Lyme disease for over 22 years in his current practice setting at Laurieton NSW just north of Newcastle, Australia. From 1991 for a few years Newcastle University researchers were offering PCR detection of Lyme disease from ticks, and from that time he found many patients with proven Lyme disease infection. Dr Mayne was the first to identify the march fly (horse fly) as another vector in Australia. In 2004 he underwent training in dermatology and later dermoscopy. His interest in the long term dermatological manifestations of Lyme disease was sharpened. In 2009 he became involved in the testing of the clinical sensitivity of PCR detection of Lyme disease at Australian Biologics with analysis of his patients to test the primers. He was then able to access PCR detection of Lyme disease again and from that he found patients with chronic Lyme disease. He now takes referrals from all over Australia, New Zealand and South East Asia. Lyme disease now forms a considerable component of his practice. Dr Mayne believes Lyme disease is not just Lyme disease, there are other tick born coinfections. In Australia these are Bartonella, Babesia microtii, Babesia duncanii and a range of the rickettsial infections three of which are unique to Australia. In collaboration with another Australian colleague there is now evidence of different clinical strains of both Babesia and Bartonella on this continent. Whilst all of these can be transmitted by ticks, fleas are known to vector Bartonella. Other arthropod vectors will undoubtedly be identified in these diseases as this is an exploding area of medical science in Australia at the moment. As well as the standard coinfections these patients will always provide evidence of other viral, bacterial and fungal infection. The striking ones are Mycoplasma including fermentans and Chlamydia pneumoniae. Dr Mayne deals with all these infections appropriately and uses ILADS guidelines for Lyme treatment. There are many patients that have been seen in his practice with diagnoses of Parkinsons, Multiple Sclerosis, Motor neurone disease and ALS where a thorough assessment has led to laboratory proof of Lyme disease. These scenarios have not been easy to treat though because of the advanced nature of the disease at presentation. Dr Mayne is actively publishing data on his Lyme work starting in December 2011 with Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. This paper as the title suggests starts to explore the incidence of lyme and those coinfections in Australia. It is the first published work on the clinical subject here for some 18 years. It has been followed by Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue which further proves the existence of lyme disease in Australia and commences the process of identification of local lyme genotypes. He has more research is to be published in the near future. Morgellons disease is a spirochaetal skin dermopathy known to be closely associated with Lyme disease. Considerable important research has been published on this matter in late 2011 and in 2012. The Charles Holman Foundation serves as the only current organisation formally interested in advancing knowledge of the disorder. Dr Mayne serves on the scientific board of the organisation and presented a talk at the last annual conference in Austin on the dermatological features and differential diagnosis of the disorder. This is the subject of his current research paper still in production. This paper will be aimed at removing the concept of delusions of parasitosis from medical terminology, and removing the social stigma of the disease particularly when children are involved. Dr Mayne assesses and treats children who have been misdiagnosed with ADD, ADHD, Autism and Aspbergers for Lyme disease and associated coinfections. He relates the joy at seeing the improvement in children with Lyme. To access a free PDF download on Dr Mayne’s publications click on the below links to Dove Press: Download: Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. Download: Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue.</ref>

+

<ref>https://beyondthebandaid.com.au/dr-peter-mayne-mbbs-sydney-dpd-cardiff-idd-graz-facrrm/ Dr Peter Mayne MBBS (Sydney) DPD (Cardiff) IDD (Graz) FACRRM Dr Peter Mayne is a Honorary teaching associate Cardiff University Department of Medicine (Dermatology) and he is also an active member of [[ILADS]] (International Lyme and Associated Diseases Society) and has undergone physician training in Lyme disease in the USA. Dr Mayne is a rural general practitioner who has been treating Lyme disease for over 22 years in his current practice setting at Laurieton NSW just north of Newcastle, Australia. From 1991 for a few years Newcastle University researchers were offering PCR detection of Lyme disease from ticks, and from that time he found many patients with proven Lyme disease infection. Dr Mayne was the first to identify the march fly (horse fly) as another vector in Australia. In 2004 he underwent training in dermatology and later dermoscopy. His interest in the long term dermatological manifestations of Lyme disease was sharpened. In 2009 he became involved in the testing of the clinical sensitivity of PCR detection of Lyme disease at Australian Biologics with analysis of his patients to test the primers. He was then able to access PCR detection of Lyme disease again and from that he found patients with chronic Lyme disease. He now takes referrals from all over Australia, New Zealand and South East Asia. Lyme disease now forms a considerable component of his practice. Dr Mayne believes Lyme disease is not just Lyme disease, there are other tick born coinfections. In Australia these are Bartonella, Babesia microtii, Babesia duncanii and a range of the rickettsial infections three of which are unique to Australia. In collaboration with another Australian colleague there is now evidence of different clinical strains of both Babesia and Bartonella on this continent. Whilst all of these can be transmitted by ticks, fleas are known to vector Bartonella. Other arthropod vectors will undoubtedly be identified in these diseases as this is an exploding area of medical science in Australia at the moment. As well as the standard coinfections these patients will always provide evidence of other viral, bacterial and fungal infection. The striking ones are Mycoplasma including fermentans and Chlamydia pneumoniae. Dr Mayne deals with all these infections appropriately and uses [[ILADS]] guidelines for Lyme treatment. There are many patients that have been seen in his practice with diagnoses of Parkinsons, Multiple Sclerosis, Motor neurone disease and ALS where a thorough assessment has led to laboratory proof of Lyme disease. These scenarios have not been easy to treat though because of the advanced nature of the disease at presentation. Dr Mayne is actively publishing data on his Lyme work starting in December 2011 with Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. This paper as the title suggests starts to explore the incidence of lyme and those coinfections in Australia. It is the first published work on the clinical subject here for some 18 years. It has been followed by Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue which further proves the existence of lyme disease in Australia and commences the process of identification of local lyme genotypes. He has more research is to be published in the near future. Morgellons disease is a spirochaetal skin dermopathy known to be closely associated with Lyme disease. Considerable important research has been published on this matter in late 2011 and in 2012. The Charles Holman Foundation serves as the only current organisation formally interested in advancing knowledge of the disorder. Dr Mayne serves on the scientific board of the organisation and presented a talk at the last annual conference in Austin on the dermatological features and differential diagnosis of the disorder. This is the subject of his current research paper still in production. This paper will be aimed at removing the concept of delusions of parasitosis from medical terminology, and removing the social stigma of the disease particularly when children are involved. Dr Mayne assesses and treats children who have been misdiagnosed with ADD, ADHD, Autism and Aspbergers for Lyme disease and associated coinfections. He relates the joy at seeing the improvement in children with Lyme. To access a free PDF download on Dr Mayne’s publications click on the below links to Dove Press: Download: Emerging Incidence of Lyme borreliosis, babesiosis, bartonellosis and granulocytic ehrlichiosis in Australia. Download: Investigation of Borrelia burgdorferi genotypes in Australia obtained from erythema migrans tissue.</ref>

== Présentation de Peter Mayne sur le site de la The Charles E. Holman Morgellons Disease Foundation ==

Pascal

12 795

modifications